跳至主要内容
临床试验/ACTRN12619001499178
ACTRN12619001499178招募中未知

A Pilot Study of FDGal-PET and Dynamic MRI Evaluation of Regional Liver Function in Patients with Liver Cancer Undergoing Surgery or Stereotactic Radiation Therapy.

Metro South Hospital and Health Services (Princess Alexandra Hospital)0 个研究点目标入组 20 人开始时间: 2019年10月30日最近更新:

试验速览

阶段
未知
状态
招募中
发起方
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Non-randomised trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • Diagnosis of primary liver cancer
  • Aged 18 or older
  • ECOG performance status 0-2
  • Diagnostic quality CT or MRI within 6 weeks of study entry.
  • Planned to undergo either surgical resection or SBRT
  • Prior liver directed or systemic therapies allowed.
  • Has provided written Informed Consent for participation in this trial and is willing to comply with the study requirements and follow-up.

排除标准

  • Patient unable to undergo MRI (e.g. non compatible pacemakers)
  • Allergic reaction attributed to compounds of similar composition to ICG, including those patients with a history of iodine or seafood allergy.
  • Women who are pregnant or lactating
  • Unwilling or unable to give informed consent

研究者

发起方
Metro South Hospital and Health Services (Princess Alexandra Hospital)

相似试验